Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 10/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.47 |
| ▸ | CD274 | Q9NZQ7 | 8/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18515009 | 0.90 | CD274 (0.41) | FFAR4FFAR1CD274ALDH1A1HSD17B10 | |
| SCHEMBL18749573 | 0.89 | MRGPRX4 (0.44) | FFAR4FFAR1CD274ALDH1A1HSD17B10 | |
| SCHEMBL18514359 | 0.88 | CD274 (0.48) | FFAR4FFAR1CD274 | |
| SCHEMBL18515524 | 0.88 | FFAR4 (0.47) | FFAR4FFAR1CD274 | |
| SCHEMBL18515114 | 0.86 | FFAR4 (0.46) | FFAR4FFAR1CD274 | |
| SCHEMBL18514935 | 0.86 | SLC22A12 (0.43) | FFAR4FFAR1CD274ALDH1A1HSD17B10 | |
| SCHEMBL18515084 | 0.86 | FFAR4 (0.46) | FFAR4FFAR1CD274 | |
| SCHEMBL18514987 | 0.84 | FFAR4 (0.39) | FFAR4FFAR1CD274ALDH1A1HSD17B10 | |
| SCHEMBL18514951 | 0.84 | FFAR4 (0.43) | FFAR4FFAR1CD274ALDH1A1HSD17B10 | |
| SCHEMBL18514934 | 0.84 | FFAR4 (0.38) | FFAR4FFAR1CD274ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9788547-B2 | Aromatic compound and uses thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-10-17 | — | — | US | disclosed |
| US-20170105416-A1 | AROMATIC COMPOUND AND USES THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-04-20 | — | — | US | disclosed |
| US-20170105413-A1 | AROMATIC COMPOUND AND USES THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-04-20 | — | — | US | disclosed |
| EP-3130584-A1 | AROMATIC COMPOUND AND USES THEREOF | Sumitomo Chemical Company Limited (JP) | 2017-02-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170105413-A1 | AROMATIC COMPOUND AND USES THEREOF | TYR, H1-3, H1-0 | FFAR4 4194/4885FFAR1 3450/4885CD274 2684/4885 |
| US-20170105416-A1 | AROMATIC COMPOUND AND USES THEREOF | TYR, H1-3, H1-10 | FFAR4 4026/4885FFAR1 3287/4885CD274 2976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.